Evaluation of Efficacy, Safety, and Tolerability of Fixed Dose Combination (FDC) of Halometasone 0.05% and Fusidic Acid 2% W/W Topical Cream Versus FDC of Betamethasone Valerate 0.12% and Neomycin Sulphate 0.5% W/W Topical Cream in the Treatment of Infected Eczematous Dermatosis in Indian Subjects: A Randomized Open-Label Comparative Phase III Multi-Centric Trial

AIM: To evaluate the efficacy and safety of fixed drug combination (FDC) halometasone 0.05% and fusidic acid 2% (group A) vs FDC betamethasone 0.12% and neomycin sulfate 0.5% cream (group B) in acute or chronic infected eczematous dermatosis, through a randomized open-label, comparative, multicentri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pratap, Dasiga Venkata Subrahmanya, Philip, Mariam, Rao, Narayana T, Jerajani, Hemangi R, Kumar, Sainath A, Kuruvila, Maria, Moodahadu, Latha S, Dhawan, Shilpi
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2013
Assuntos:
Therapeutic Round
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3657210/
https://ncbi.nlm.nih.gov/pubmed/23716800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.108041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados